Oral use of iron with vitamin C in hemodialyzed patients

Journal of Renal Nutrition

Volumn 13, Issue 1, 2003, Pages 47-51

  Mydlík, Miroslav ^a   Derzsiová, Katarína ^a   Boldizsár, Ján ^b   Hríbiková, Mária ^b   Petrovičová, Jozefína ^c  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b District Hospital   (Slovakia)

^c P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM CARBONATE; FERRITIN; FERROUS SULFATE; FOLIC ACID; HEMOGLOBIN; IRON; OXALIC ACID; PYRIDOXINE; RECOMBINANT ERYTHROPOIETIN; SORBIFER; TRANSFERRIN; CREATININE; OXALIC ACID DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON THERAPY; KIDNEY FAILURE; MALE; OPEN STUDY; SIDE EFFECT; VITAMIN BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; IRON DEFICIENCY ANEMIA; IRON INTAKE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; ASCORBIC ACID; CREATININE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; IRON, DIETARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXALATES; RENAL DIALYSIS; TRANSFERRIN;

EID: 0038201763     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/jren.2003.50007     Document Type: Article

References (19)

1. Eschbach JW, Egrie JC, Downing MR, et al: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316:73-78, 1987
2. Hörl WH: Is there a role for adjuvant therapy in patients being treated with epoetin? Nephrol Dial Transplant 14:50-60, 1999 (suppl)
3. 6 and its requirements in chronic renal failure. Kidney Int 52:56-59, 1997 (suppl)
4. Fishbane S, Frei GI, Maesaka J: Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 26:41-46, 1995
5. Tarng GC, Wei YH, Huang TP, et al: Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in haemodialysis patients with hyperferritinemia. Kidney Int 55:2477-2486, 1999
6. Tonbul HZ, Kaya H, Selcuk NY, et al: The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in haemodialysis patients. Int Urol Nephrol 30:645-651, 1998
7. Macdougall IC: Metabolic adjuvants to erythropoietin therapy. Miner Electrolyte Metab 25:357-364, 1999
8. Macdougall IC, Tucker B, Thompson J, et al: A randomized randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 50:1694-1699, 1996
9. Wingard RL, Parker RA, Ismail N, et al: Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 25:433-439, 1995
10. Tarng DC, Huang TP, Chen TW, et al: Erythropoietin hyporesponsiveness: From iron deficiency to iron overload. Kidney Int 55:107-108, 1999 (suppl)
11. Hallberg L, Brune M, Rossander L: The role of vitamin C in iron absorption. Int J Vitam Nutr Res 30:103-108, 1989 (suppl)
12. Pru C, Ealton J, Kjellstrand C: Vitamin C intoxication and hyperoxalemia in chronic hemodialysis patients. Nephron 39:112-116, 1985
13. Ono K: Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients. Clin Nephrol 26:239-243, 1986
14. Tomson CR, Channon SM, Ward MK, et al: Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis. Nephrol Dial Transplant 4:792-799,1989
15. Rivers JM: Safety of high-level vitamin C ingestion. Int J Vitam Nutr Res 30:95-102, 1989 (suppl)
16. Makoff R: Vitamins replacement therapy in renal failure patients. Miner Electrolyte Metab 25:349-351, 1999
17. Caraway WT: Macro and micro methods for the determination of serum iron and iron-binding capacity. Clin Chem 9:188-199, 1963
18. Hořejší J (ed): The Fundamentals of Chemical Investigation in Medicine, ed 6. Prague, Státní Zdravotnícké Nakladatelství, 1964
19. Rolton HA, McConnel KN, Modi KS, et al: A simple, rapid assay for plasma oxalate in uraemic patients using oxalate oxidase, which is free from vitamin C interference. Clin Chim Acta 182:247-254, 1989